http://www.modernmedicine.com/modernmedicine/BPH/Article/list/40243 Clinical information, articles, medical news and research about benign prostatic hyperplasia or benign prostatic hypertrophy. Diagnosis and treatment information including decision support tools for formulary and ICD-9 codes. 2009-11-21T22:11:48Z http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Research-points-to-expanding-role-of-botulinum-tox/ArticleStandard/Article/detail/637943?contextCategoryId=40243&ref=25 In this interview, Michael B. Chancellor, MD, discusses using botulinum toxin for treating overactive bladder, BPH, interstitial cystitis, and other conditions. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637943null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Majority-of-nocturia-patients-have-nocturnal-polyu/ArticleStandard/Article/detail/637925?contextCategoryId=40243&ref=25 A study shows that most patients with nocturia have nocturnal polyuria, which is consistent with other studies showing that overproduction of urine at night is a major contributory factor to nocturia in about 80% of patients. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637925null XML http://www.modernmedicine.com/modernmedicine/Enews/Combination-therapy-offers-benefits-for-men-with-B/ArticleStandard/Article/detail/636242?contextCategoryId=40243&ref=25 Final results from a large, 4-year study shows that combination treatment with dutasteride (Avodart) and tamsulosin (Flomax) reduces the risk of acute urinary retention or BPH-related surgery and reduces the risk of BPH clinical progression more than tamsulosin alone. 2009-10-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/432009/636242null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Researchers-Evaluate-New-Prostate-Specific-Antigen/ArticleNewsFeed/Article/detail/636333?contextCategoryId=40243&ref=25 A new test for prostate-specific antigen levels is considerably more sensitive than commercial assays and allows better monitoring for recurrence after prostatectomy for early-stage prostate cancer, according to a study published online Oct. 19 in the Proceedings of the National Academy of Sciences. 2009-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636333/Mic093ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636333null XML http://www.modernmedicine.com/modernmedicine/Endocrinology/Study-Evaluates-Hospital-Quality-and-Mortality-Rat/ArticleNewsFeed/Article/detail/633747?contextCategoryId=40243&ref=25 Hospital mortality rates in the United States have improved, although major differences in quality still exist between the best and worst hospitals, according to a report published Oct. 13 by HealthGrades. 2009-10-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747/hospitalsign_18169.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Combination-May-Improve-Prostate-Cancer-Prediction/ArticleNewsFeed/Article/detail/631560?contextCategoryId=40243&ref=25 Combining endorectal MRI, magnetic resonance spectroscopy, and a low free-to-total prostate-specific antigen ratio is highly accurate in predicting prostate cancer in men with high PSA levels, according to a European study in the October issue of Radiology. 2009-10-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631560/depressedman.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631560null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Alcohol-Found-to-Lessen-Risk-for-Enlarged-Prostate/ArticleNewsFeed/Article/detail/629035?contextCategoryId=40243&ref=25 A man's risk of developing benign prostatic hyperplasia decreases as his consumption of alcohol increases, but not the risk of lower urinary tract symptoms, according to a meta-analysis reported in the October issue of the Journal of Urology. 2009-09-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629035/SS42069.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629035null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Two-thirds-of-BPHLUTS-patients-dont-receive-meds/ArticleStandard/Article/detail/624485?contextCategoryId=40243&ref=25 BPH and lower urinary tract symptoms are very common, increase as a function of age, and are often managed through watchful waiting. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624485null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Light-activated-BPH-therapy-safe-painless/ArticleStandard/Article/detail/624465?contextCategoryId=40243&ref=25 Light-activated drug therapy for BPH has been shown to be safe and painless in a phase I/II trial. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624465null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Multidisciplinary-Approach-Recommended-for-Pelvic-/ArticleNewsFeed/Article/detail/612330?contextCategoryId=40243&ref=25 In a commentary on three diverse studies in the August Journal of Urology, a leading urologist advocates a multidisciplinary approach to unravel the complex pathologies of pelvic pain, prostatitis, painful bladder syndrome, and interstitial cystitis. 2009-07-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612330/pelvis_59279.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612330null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostate-Condition-Symptoms-Linked-to-Ejaculation-/ArticleNewsFeed/Article/detail/608996?contextCategoryId=40243&ref=25 Urologists treating patients with lower urinary tract symptoms, which suggest benign prostatic hyperplasia, should counsel patients on the increased risk that LUTS/BPH and BPH treatment present for ejaculatory dysfunction, according to a literature review published in the July issue of Urology. 2009-07-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/282009/608996/prostate.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/282009/608996null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/How-to-manage-BOO-with-temporary-prostatic-stentin/ArticleStandard/Article/detail/606047?contextCategoryId=40243&ref=25 This article will help urologists to quickly gain experience and confidence in temporary prostatic stenting and to incorporate use of a new stent device into their clinical practice. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/262009/606047null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Office-Urologic-Procedures-Pose-Little-Risk/ArticleNewsFeed/Article/detail/605192?contextCategoryId=40243&ref=25 Cystoscopy and transrectal ultrasound-guided prostate biopsy performed in the office setting appear to pose minimal risk to patients, according to research published in the June issue of Urology. 2009-06-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/605192null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Digital-Rectal-Exam-Remains-Key-in-Men-With-Low-PS/ArticleNewsFeed/Article/detail/605195?contextCategoryId=40243&ref=25 Due to the number of men who may have aggressive prostate cancers despite a low prostate specific antigen, digital rectal exams remain important in detecting early cancer, according to research published in the June issue of the Journal of Urology. 2009-06-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/605195/FAC070small.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/605195null XML http://www.modernmedicine.com/modernmedicine/Enews/BPH-drug-shown-to-raise-risk-of-adverse-events-aft/ArticleStandard/Article/detail/601983?contextCategoryId=40243&ref=25 Patients treated with tamsulosin (Flomax) for BPH prior to cataract surgery have more than twice the risk of experiencing an adverse event, according to physicians from the Institute for Clinical Evaluative Sciences and St. Michael?s Hospital, Toronto. 2009-06-11T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232009/601983null HTML http://www.modernmedicine.com/modernmedicine/Managed+Care/Dry-Eye-Affects-168-Million-Older-Men-in-US/ArticleNewsFeed/Article/detail/603019?contextCategoryId=40243&ref=25 Dry eye disease affects 1.68 million U.S. men age 50 and older, and those who have high blood pressure, an enlarged prostate, or use antidepressants are at elevated risk, according to a study reported in the June Archives of Ophthalmology. 2009-06-11T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242009/603019/33101.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242009/603019null XML http://www.modernmedicine.com/modernmedicine/Pathology/Signaling-Network-Identified-in-Prostatic-Hyperpla/ArticleNewsFeed/Article/detail/602001?contextCategoryId=40243&ref=25 Analysis of a rat model of benign prostatic hyperplasia has identified a cellular signaling network and targets that could be exploited for therapeutics, according to a study published online May 14 in Endocrinology. 2009-06-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/602001/prostate.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/602001null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/BPH-related-symptoms-improve-with-PDE-5-inhibitor/ArticleStandard/Article/detail/602359?contextCategoryId=40243&ref=25 Findings from a multicenter, randomized, double-blind, placebo-controlled study are consistent with previously reported data showing that tadalafil (Cialis) improves lower urinary tract symptoms associated with BPH. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/242009/602359null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Alpha-blocker-then-TWOC-Global-standard-for-acute-/ArticleStandard/Article/detail/595547?contextCategoryId=40243&ref=25 The largest worldwide survey of acute urinary retention (AUR) ever performed suggests treatment with an alpha-blocker and trial without catheter (TWOC) within 3 days after AUR is the worldwide standard of care. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/182009/595547null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Injectable-agents-may-expand-options-for-BPH/ArticleStandard/Article/detail/595548?contextCategoryId=40243&ref=25 While medical therapy remains the mainstay of treatment for most men with symptomatic BPH and surgery is required for severe, progressive disease, injectables may offer a number of theoretical advantages. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/182009/595548null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Targeted-BPH-treatment-safe-effective-at-1-year/ArticleStandard/Article/detail/595551?contextCategoryId=40243&ref=25 Transperineal intraprostatic injection of a PSA-activated protoxin (PRX302) provides lasting symptomatic relief and improvement in quality of life for men with BPH, according to 1-year follow-up data from a phase I study. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/182009/595551null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-alpha-blocker-highly-selective-for-urinary-tra/ArticleStandard/Article/detail/595562?contextCategoryId=40243&ref=25 A new alpha-blocker for the treatment of BPH shows positive results with minimal cardiovascular side effects, according to a presentation made during the European Association of Urology annual congress 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/182009/595562null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Two-drug-therapy-effective-in-lower-urinary-tract-/ArticleStandard/Article/detail/595583?contextCategoryId=40243&ref=25 Anticholinergic drugs also are effective and safe in men who have lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO) secondary to BPH, a new study suggests. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/182009/595583null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AUA-Panel-Addresses-Prostate-Screening-Controversi/ArticleNewsFeed/Article/detail/595192?contextCategoryId=40243&ref=25 Some restrictions on prostate-specific antigen testing could result in substantial cost savings without compromising patient safety, according to research presented during an expert panel session at the annual meeting of the American Urological Association held April 25 to 30 in Chicago. 2009-04-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/595192/blood_18089.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/595192null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AUA-Statins-Have-Wide-Range-of-Urological-Benefits/ArticleNewsFeed/Article/detail/595193?contextCategoryId=40243&ref=25 A growing body of evidence suggests that statins are associated with multiple urological benefits in men, according to six studies presented during an expert panel session at the American Urological Association annual meeting held April 25 to 30 in Chicago. 2009-04-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/595193/54184.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/595193null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Discontinuing-Drugs-for-BPH-May-Prove-Harmful/ArticleNewsFeed/Article/detail/594822?contextCategoryId=40243&ref=25 Discontinuing combination therapy for benign prostate hyperplasia (BPH) leads to increased prostate volume and worsening of symptoms, according to a study in the April issue of Urology. 2009-04-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594822/waitingroom_40308.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594822null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pelvic-Cooling-Technique-Beneficial-in-Prostatecto/ArticleNewsFeed/Article/detail/593774?contextCategoryId=40243&ref=25 Hypothermic nerve-sparing radical prostatectomy is a safe and feasible procedure that results in an earlier return to continence, according to a report published in the April issue of Urology. 2009-04-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593774/man_walking_33047.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593774null XML http://urologytimes.modernmedicine.com/urologytimes/BPH/Creating-a-New-Standard-of-Care-for-BPH/ArticleStandard/Article/detail/589435?contextCategoryId=40243&ref=25 Creating a New Standard of Care for BPH Supplement for April 15, 2009 Urology Times Issue 2009-03-25T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/132009/589435null PDF http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/ASCO-GU-Prostate-Cancer-Prevention-Talk-Advised/ArticleNewsFeed/Article/detail/583639?contextCategoryId=40243&ref=25 Healthy men should talk to their doctors about taking a 5-alpha reductase inhibitor (5-ARI) to reduce their risk of prostate cancer, according to a joint guideline published online Feb. 24 in the Journal of Clinical Oncology by the American Society of Clinical Oncology and the American Urological Association, and released to coincide with the American Society of Clinical Oncology's Genitourinary Cancers Symposium held Feb. 26 to 28 in Orlando. The guidelines will also appear in the March issue of the Journal of Urology. 2009-02-26T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583639/physician_18134.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583639null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Survey-Respondents-Frown-on-UKs-Plans-for-Flomax/ArticleNewsFeed/Article/detail/575523?contextCategoryId=40243&ref=25 Most readers surveyed by the journal Drug and Therapeutics Bulletin are not in favor of the UK's Medicines and Healthcare Products Regulatory Agency's plans to possibly make trimethoprim and tamsulosin (Flomax) available over the counter, according to a release issued Jan. 14. 2009-01-14T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/032009/575523/physician_18141.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/032009/575523null XML http://www.modernmedicine.com/modernmedicine/News/Investigational-benign-prostatic-hyperplasia-drug-/ArticleStandard/Article/detail/571875?contextCategoryId=40243&ref=25 Patients receiving NX-1207, an investigational drug for BPH, experienced significant quantitative improvement in urgency and frequency of urination, according to Nymox Pharmaceuticals, the drug's manufacturer. 2008-12-18T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/512008/571875null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/NSAIDs-Are-Safe-Effective-for-Prostatectomy-Pain/ArticleNewsFeed/Article/detail/570745?contextCategoryId=40243&ref=25 The use of non-steroidal anti-inflammatory drugs (NSAIDs) appears to be safe and effective for pain relief following radical retropubic prostatectomy, according to research published in the December issue of Urology. 2008-12-09T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/502008/570745/scalpel_59022.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/502008/570745null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Urologic-Diseases-project-enters-bold-second-phase/ArticleStandard/Article/detail/567565?contextCategoryId=40243&ref=25 In this interview, Mark S. Litwin, MD, MPH discusses the NIDDK-funded Urologic Diseases in America (UDA) project, which is now in its second phase. 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/472008/567565null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anticipate-silodosin-intraoperative-floppy-iris-sy/ArticleStandard/Article/detail/568123?contextCategoryId=40243&ref=25 History-taking is a little more time-consuming for cataract surgeons with the recent FDA approval of silodosin capsules (Rapaflo, Watson) for the treatment of symptoms due to benign prostatic hyperplasia. 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/482008/568123null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Rapaflo-silodosin-Alpha-blocker-approved-for-the-t/ArticleStandard/Article/detail/569884?contextCategoryId=40243&ref=25 New molecular entity: Silodosin (Rapaflo), an alpha-blocker, was approved on October 8, 2008, for the treatment of the signs and symptoms of BPH 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/formulary/492008/569884null XML http://www.modernmedicine.com/modernmedicine/News/REDUCE-trial-links-prostate-inflammation-lower-uri/ArticleStandard/Article/detail/566498?contextCategoryId=40243&ref=25 Evidence of a relationship between prostate inflammation and lower urinary tract symptoms exists in men enrolled in the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial, a 4-year, phase III, placebo-controlled study that evaluates whether dutasteride (Avodart) decreases the risk of biopsy-detectable prostate cancer. 2008-11-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/472008/566498null HTML http://www.modernmedicine.com/modernmedicine/BPH/New-prostate-treatments-reflect-expanding-patient-/ArticleStandard/Article/detail/562971?contextCategoryId=40243&ref=25 As baby boomers age, the pool of patients needing prostate treatment is expanding dramatically. With more patients asking questions, pharmacists need to be ready with answers. 2008-11-10T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/drugtopics/452008/562971null XML http://www.modernmedicine.com/modernmedicine/Industry+News/Anticipate-silodosin-IFIS-link-surgeon-says/ArticleStandard/Article/detail/563092?contextCategoryId=40243&ref=25 History-taking is a little more time-consuming for cataract surgeons with the recent FDA approval of silodosin capsules (Rapaflo, Watson) for the treatment of symptoms due to benign prostatic hyperplasia. 2008-11-05T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452008/563092null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Finasteride-not-associated-with-increased-risk-of-/ArticleStandard/Article/detail/562936?contextCategoryId=40243&ref=25 A study published in the Journal of the American Medical Association reported that use of finasteride, a 5-alpha reductase inhibitor commonly used to treat benign prostatic hyperplasia (BPH), does not appear to be associated with an increased incidence of hip fractures in men; in fact, the agent appears to decrease the risk of hip fracture. 2008-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/formulary/452008/562936null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Statins-Lower-Prostate-Specific-Antigen-Levels/ArticleNewsFeed/Article/detail/561899?contextCategoryId=40243&ref=25 Statin treatment significantly lowers levels of prostate-specific antigen (PSA), particularly in men with large drops in low-density lipoprotein (LDL) and in those whose pre-statin PSA levels would have made them candidates for a prostate biopsy, according to a study published online Oct. 28 in the Journal of the National Cancer Institute. 2008-10-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442008/561899/waitingroom_40308.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442008/561899null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Single-Adult-Stem-Cell-Can-Lead-to-Mouse-Prostate/ArticleNewsFeed/Article/detail/561113?contextCategoryId=40243&ref=25 A single adult mouse prostate stem cell is capable of generating a prostate after being transplanted in vivo, according to a letter published online Oct. 22 in the journal Nature. 2008-10-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432008/561113/29072.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432008/561113null XML http://www.modernmedicine.com/modernmedicine/News/Many-patients-misunderstand-IPSS-other-screening-t/ArticleStandard/Article/detail/559937?contextCategoryId=40243&ref=25 A profound gap exists in the understanding of physicians about the literacy levels of their patients related to the efficacy of written screening tools, including the International Prostate Symptom Score, researchers from Emory University School of Medicine, Atlanta, reported. 2008-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/432008/559937null HTML http://www.modernmedicine.com/modernmedicine/News/Benign-prostatic-hyperplasia-medications-not-assoc/ArticleStandard/Article/detail/559929?contextCategoryId=40243&ref=25 Use of 5-alpha-reductase inhibitors is not associated with increased risk of hip fracture, according to a study published in JAMA (2008; 300:1660-4). 2008-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/432008/559929null HTML http://www.modernmedicine.com/modernmedicine/News/FDA-approves-once-daily-BPH-treatment/ArticleStandard/Article/detail/559831?contextCategoryId=40243&ref=25 Watson Pharmaceuticals has received FDA approval to market silodosin (Rapaflo), an alpha-blocker for the treatment of BPH signs and symptoms. 2008-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/432008/559831null HTML http://www.modernmedicine.com/modernmedicine/News/Investigational-BPH-therapies-yield-promising-resu/ArticleStandard/Article/detail/556700?contextCategoryId=40243&ref=25 Two investigational BPH therapies are yielding positive efficacy results in men with the condition, according to studies presented at recent AUA section meetings. 2008-10-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/412008/556700null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/5-alpha-Reductase-Inhibitors-Not-Linked-to-Higher-/ArticleNewsFeed/Article/detail/557096?contextCategoryId=40243&ref=25 The use of 5-α reductase inhibitors for treatment of benign prostatic hyperplasia does not appear to raise the risk of hip fracture, and may even reduce the risk modestly, according to research published in the Oct. 8 issue of the Journal of the American Medical Association. 2008-10-07T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412008/557096/cane_SS36051.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412008/557096null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Celecoxib-May-Benefit-Benign-Prostatic-Hyperplasia/ArticleNewsFeed/Article/detail/555986?contextCategoryId=40243&ref=25 Celecoxib is a novel treatment option for patients with benign prostatic hyperplasia experiencing refractory nocturia, according to a report in the October issue of Urology. 2008-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555986/celebrex.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555986null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Metabolic-Syndrome-Linked-to-Prostate-Specific-Ant/ArticleNewsFeed/Article/detail/555687?contextCategoryId=40243&ref=25 Prostate-specific antigen levels are influenced by both age and components of the metabolic syndrome, according to study findings published in the October issue of Urology. 2008-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555687/manstomachsmall.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555687null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Catheter-Free-Prostate-Treatment-Safe-and-Effectiv/ArticleNewsFeed/Article/detail/555194?contextCategoryId=40243&ref=25 The catheter-free lithium triborate laser photoselective vaporization prostatectomy is both safe and effective for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia, according to a report in the October issue of Lasers in Surgery and Medicine. 2008-09-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555194/patient_18248.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555194null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Obesity-and-Prostate-Specific-Antigen-Inversely-Re/ArticleNewsFeed/Article/detail/550845?contextCategoryId=40243&ref=25 An inverse relationship between obesity and serum prostate-specific antigen levels exists even among populations with a low prevalence of obesity, and may need to be taken into account when screening men for prostate cancer, researchers report in the September issue of Urology. 2008-09-17T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382008/550845/18308.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382008/550845null XML http://www.modernmedicine.com/modernmedicine/Enews/Daily-tadalafil-may-relieve-urinary-symptoms-in-me/ArticleStandard/Article/detail/548455?contextCategoryId=40243&ref=25 A daily dose of tadalafil (Cialis) may relieve lower urinary tract symptoms in men with BPH symptoms, according to a study published in the Aug. 21 online edition of The Journal of Urology. 2008-09-11T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372008/548455null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Painkillers-Affect-Prostate-Specific-Antigen-Level/ArticleNewsFeed/Article/detail/548921?contextCategoryId=40243&ref=25 Prostate-specific antigen levels may be reduced by regular use of non-steroidal anti-inflammatory drugs, according to research published online Sept. 8 in Cancer. 2008-09-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372008/548921/pillbottle_59037.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372008/548921null XML http://www.modernmedicine.com/modernmedicine/BPH/5-alpha-reductase-inhibitor-improves-lower-urinary/ArticleStandard/Article/detail/548545?contextCategoryId=40243&ref=25 Long-term treatment with finasteride resulted in consistent, clinically significant reductions in total prostate volume regardless of baseline volume. 2008-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372008/548545null XML http://www.modernmedicine.com/modernmedicine/BPH/Transurethral-resection-of-the-prostate-photoselec/ArticleStandard/Article/detail/548542?contextCategoryId=40243&ref=25 Men facing treatment for benign prostatic hyperplasia can expect similar outcomes after transurethral resection of the prostate or photoselective vaporization of the prostate. 2008-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372008/548542null XML http://www.modernmedicine.com/modernmedicine/BPH/Alpha-blocker-iris-syndrome-link-still-a-concern/ArticleStandard/Article/detail/548544?contextCategoryId=40243&ref=25 Despite a 2-year-old advisory by AUA and two leading ophthalmology groups concerning a possible complication of cataract surgery in men taking tamsulosin, awareness of the problem has failed to reach many prescribers and patients 2008-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372008/548544null XML http://www.modernmedicine.com/modernmedicine/BPH/Vitamin-D-agonist-slows-benign-prostatic-hyperplas/ArticleStandard/Article/detail/548569?contextCategoryId=40243&ref=25 An investigational vitamin D agonist significantly slowed prostate growth and improved prostate symptoms and urinary flow in men with symptomatic benign prostatic hyperplasia. 2008-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372008/548569null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Surgery-for-Urinary-Tract-Symptoms-in-Men-Benefici/ArticleNewsFeed/Article/detail/543729?contextCategoryId=40243&ref=25 Elderly men who have undergone transurethral resection of the prostate generally have long-term improvement in lower urinary tract symptoms, quality of life and satisfaction, researchers report in the August issue of Urology. 2008-08-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543729/balding_45200.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543729null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Tadalafil-Offers-Benefits-for-Benign-Prostatic-Hyp/ArticleNewsFeed/Article/detail/543569?contextCategoryId=40243&ref=25 Daily treatment with tadalafil can relieve lower urinary tract symptoms in men with benign prostatic hyperplasia, according to research released online Aug. 19 in advance of publication in the October issue of the Journal of Urology. 2008-08-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543569/pillbottle_59037.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543569null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Urologist-Caseload-Volume-May-Affect-Patient-Outco/ArticleNewsFeed/Article/detail/543305?contextCategoryId=40243&ref=25 Urologists who perform more transurethral resections of the prostate may have lower rates of patient in-hospital mortality, according to an article published in the August issue of Urology. 2008-08-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543305/scalpel_59026.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543305null XML http://www.modernmedicine.com/modernmedicine/Enews/NIDDK-publishes-strategic-plan-for-benign-prostate/ArticleStandard/Article/detail/534933?contextCategoryId=40243&ref=25 For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases. 2008-08-14T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/332008/534933null HTML http://www.modernmedicine.com/modernmedicine/Prostate+Cancer/Finasteride-supported-as-chemoprevention-in-prosta/ArticleStandard/Article/detail/534004?contextCategoryId=40243&ref=25 Leading European urologists have reviewed the findings from the Prostate Cancer Prevention Trial (PCPT) and have reached consensus supporting the use of finasteride (Proscar) as a chemopreventive agent for the disease. A similar consensus statement in the United States appears to be coming soon. 2008-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/322008/534004null XML http://www.modernmedicine.com/modernmedicine/Urology/Urologic-pelvic-pain-Diagnosis-and-management/ArticleStandard/Article/detail/533973?contextCategoryId=40243&ref=25 Urologic pelvic pain is a debilitating condition that affects significant numbers of men and women during their lifetime. Diverse disease states, physiologic conditions, and lifestyle factors may cause or exacerbate pain, challenging diagnosis and treatment efforts. We outline the fundamentals of a multimodal approach to managing urologic pelvic pain. 2008-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/322008/533973/utce0808_cv1_15518_main_thumbnail.jpg http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/322008/533973null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Robotic-Prostatectomy-Review-Points-to-Positive-Ou/ArticleNewsFeed/Article/detail/530981?contextCategoryId=40243&ref=25 A review of articles comparing robotically assisted prostatectomies with open and laparoscopic procedures offers data on outcomes to help guide surgical choice. The review was published in the July issue of Urology. 2008-07-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/530981/surgeon_18066.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/530981null XML http://www.modernmedicine.com/modernmedicine/Industry+News/ASCRS-AAO-have-new-advice-for-primary-care-physici/ArticleStandard/Article/detail/528574?contextCategoryId=40243&ref=25 The American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery are working with the American College of Physicians and the American Academy of Family Physicians to educate prescribers of tamsulosin (Flomax, Boehringer Ingelheim) about the association between the use of alpha blockers and intraoperative floppy eye syndrome. 2008-07-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/282008/528574null HTML http://www.modernmedicine.com/modernmedicine/News/Use-of-minimally-invasive-BPH-treatment-up-signifi/ArticleStandard/Article/detail/528375?contextCategoryId=40243&ref=25 Use of minimally invasive surgical treatments (MISTs) for BPH has increased tremendously in the past decade, but urologists should be careful about overusing these newer technologies, given the lack of long-term evidence of their efficacy, according to researchers from the University of Minnesota, Minneapolis. 2008-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/282008/528375null XML http://www.modernmedicine.com/modernmedicine/Top+Story/Best-of-AUA-Orlando-2008/ArticleStandard/Article/detail/528391?contextCategoryId=40243&ref=25 In its 103rd installment, the AUA annual meeting introduced urologists to interesting research about relationships between urologic conditions and other significant health issues. The annual take-home messages are presented here. 2008-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/282008/528391null XML http://www.modernmedicine.com/modernmedicine/BPH/FDA-gives-nod-to-combination-treatment-for-BPH/ArticleStandard/Article/detail/525994?contextCategoryId=40243&ref=25 FDA has approved the 5-alpha-reductase inhibitor dutasteride (Avodart) in combination with the alpha-blocker tamsulosin (Flomax) for treatment of symptomatic enlarged prostate. Both drugs had previously been approved individually for treatment of enlarged prostate. 2008-06-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/262008/525994null HTML http://www.modernmedicine.com/modernmedicine/Oncology/Needle-Guide-Type-Affects-Prostate-Biopsy-Complica/ArticleNewsFeed/Article/detail/522577?contextCategoryId=40243&ref=25 In men undergoing transrectal prostate biopsy, the use of a disposable ultrasound needle guide may significantly reduce the rate of infectious complications, according to research published in the June issue of Urology. 2008-06-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242008/522577/prostate_cancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242008/522577null XML http://www.modernmedicine.com/modernmedicine/News/Alpha-blocker-raises-success-of-trial-without-cath/ArticleStandard/Article/detail/520522?contextCategoryId=40243&ref=25 A trial without catheter (TWOC) following an average of 3 days of catheterization has become standard practice in men with acute urinary retention (AUR) associated with BPH. Now, the results of a recent study have shown that the administration of an alpha-blocker prior to a TWOC can significantly increase the chances of the success of TWOC. 2008-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232008/520522null XML http://www.modernmedicine.com/modernmedicine/News/Therapy-combination-superior-in-high-risk-BPH-pati/ArticleStandard/Article/detail/520517?contextCategoryId=40243&ref=25 The combination of dutasteride (Avodart) and tamsulosin (Flomax) provides significantly greater improvement in International Prostate Symptom Score (IPSS) and patient-reported quality of life than either therapy alone in men with BPH who are at increased risk of progression. 2008-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232008/520517null XML http://www.modernmedicine.com/modernmedicine/BPH/TURP-Superior-results-confirm-value-in-treating-BP/ArticleStandard/Article/detail/515199?contextCategoryId=40243&ref=25 A leading BPH researcher has presented data demonstrating the persistent value and utility of a time-tested treatment: monopolar transurethral resection of the prostate. 2008-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/192008/515199null XML http://www.modernmedicine.com/modernmedicine/BPH/KTP-laser-shows-good-results-in-BPH-at-4-years/ArticleStandard/Article/detail/515201?contextCategoryId=40243&ref=25 Treatment of lower urinary tract symptoms using an 80-watt laser prostatectomy system showed a significant decrease in IPSS and post-void residual urine, among other positive indicators. 2008-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/192008/515201null XML http://www.modernmedicine.com/modernmedicine/News/Phytotherapy-to-treat-BPH-Selective-success-or-fut/ArticleStandard/Article/detail/515194?contextCategoryId=40243&ref=25 Although much of the argument supporting phytotherapy for lower urinary tract symptoms and BPH is flawed, this therapy appears to work well enough to make it a viable choice for patients with moderate symptoms and low bother scores. 2008-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/192008/515194null XML http://www.modernmedicine.com/modernmedicine/BPH/Two-injectable-BPH-drugs-reach-clinical-trial-mile/ArticleStandard/Article/detail/511627?contextCategoryId=40243&ref=25 Two injectable drugs for the treatment of BPH are approaching critical milestones: one, a phase II trial of the investigational drug NX-1207; the other, enrollment in the first of three multicenter phase III trials of cetrorelix. 2008-04-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/172008/511627null HTML http://www.modernmedicine.com/modernmedicine/Nursing/Prostate-Biopsy-Approaches-Have-Similar-Detection-/ArticleNewsFeed/Article/detail/501705?contextCategoryId=40243&ref=25 Transperineal and transrectal approaches for prostate biopsy give similar cancer detection and complication rates in men with elevated prostate-specific antigen levels, researchers report in the February issue of Urology. 2008-03-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/501705/mic008.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/501705null XML http://www.modernmedicine.com/modernmedicine/Nursing/Isoflavone-Extract-Lowers-Prostate-Specific-Antige/ArticleNewsFeed/Article/detail/500901?contextCategoryId=40243&ref=25 A daily isoflavone extract significantly reduces prostate-specific antigen (PSA) levels in men with elevated PSA levels and negative prostate biopsy, according to study findings published in the February issue of Urology. 2008-03-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/500901/bloodresults_18095.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/500901null XML http://www.modernmedicine.com/modernmedicine/BPH/Two-drug-therapy-improves-BPH-symptoms/ArticleStandard/Article/detail/486689?contextCategoryId=40243&ref=25 Men with BPH who take a combination of dutasteride (Avodart) and tamsulosin (Flomax) appear to experience significantly greater improvement in urinary symptoms than do men taking either medication alone, according to findings from the CombAT (Combination of Avodart and Tamsulosin) study. 2008-01-31T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/042008/486689null HTML http://www.modernmedicine.com/modernmedicine/BPH/HoLEP-in-BPH-shows-safety-efficacy-durability/ArticleStandard/Article/detail/482231?contextCategoryId=40243&ref=25 Three studies suggest that holmium laser enucleation of the prostate (HoLEP) is efficacious and safe, and that outcomes are durable. 2008-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/022008/482231null XML http://www.modernmedicine.com/modernmedicine/BPH/Prostate-doubling-time-may-be-valuable-prognostic-/ArticleStandard/Article/detail/482230?contextCategoryId=40243&ref=25 The pace of prostate growth in a majority of men of northern European descent is as steady as a ticking clock and gives clinicians the opportunity to forecast prostate size in many patients with a single ultrasound measurement. 2008-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/022008/482230null XML http://www.modernmedicine.com/modernmedicine/Oncology/Percent-Free-PSA-Questioned-for-Cancer-Diagnosis/ArticleNewsFeed/Article/detail/481391?contextCategoryId=40243&ref=25 Using percent free prostate specific antigen (PSA) added no benefit in diagnosing prostate cancer compared to using total PSA, according to research published in the January issue of the Journal of Urology. 2007-12-28T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/522007/481391/prostate_cancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/522007/481391null XML http://www.modernmedicine.com/modernmedicine/BPH/BPH---resources/CustomizableHandout/Article/detail/554275?contextCategoryId=40243&ref=25 Resources - BPH 2007-12-19T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/customizablehandout/modernmedicine/402008/554275null XML http://www.modernmedicine.com/modernmedicine/BPH/AUR-may-foreshadow-increased-morbidity-mortality/ArticleStandard/Article/detail/475193?contextCategoryId=40243&ref=25 Clinicians confronting acute urinary retention (AUR) would do well to not only resolve the retention, but to also look for and treat comorbid disease, which amplifies the risk of death in a disease state already associated with a high incidence of mortality. 2007-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/482007/475193null XML http://www.modernmedicine.com/modernmedicine/Oncology/High-Carbohydrate-Diet-Promotes-Cancer-Growth-in-M/ArticleNewsFeed/Article/detail/475814?contextCategoryId=40243&ref=25 A high-carbohydrate/high-fat diet promotes tumor growth in a mouse model of prostate cancer more than a low-carbohydrate/high-fat diet, according to study findings published online Nov. 27 in the Journal of the National Cancer Institute. 2007-11-28T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/482007/475814/mouse.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/482007/475814null XML http://www.modernmedicine.com/modernmedicine/Oncology/Men-in-40s-Less-Interested-in-PSA-Testing-Than-Old/ArticleNewsFeed/Article/detail/473514?contextCategoryId=40243&ref=25 Men between the ages of 45 and 49 accept invitations for prostate cancer screening at a much lower rate than older men, according to research published Nov. 15 in BMJ Online First. 2007-11-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462007/473514/prostate_cancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462007/473514null XML http://www.modernmedicine.com/modernmedicine/Urology/Study-Examines-Mortality-Risk-in-Acute-Urinary-Ret/ArticleNewsFeed/Article/detail/471620?contextCategoryId=40243&ref=25 Mortality rates in men hospitalized for a first episode of acute urinary retention are high, with one in four men dying within a year when the cause of urinary retention is unrelated to prostatic enlargement, and one in seven dying when prostatic enlargement is the cause, according to a report published online Nov. 8 in BMJ Online First. 2007-11-09T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452007/471620/xray_MIC079ML.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452007/471620null XML http://www.modernmedicine.com/modernmedicine/BPH/Enlarged-prostate/CustomizableHandout/Article/detail/554027?contextCategoryId=40243&ref=25 The prostate is a male reproductive gland that produces the fluid that carries sperm during ejaculation. It surrounds the urethra, the tube through which urine passes out of the body. 2007-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/customizablehandout/modernmedicine/402008/554027null XML http://www.modernmedicine.com/modernmedicine/Urology/Urethral-Strictures-Associated-with-Early-Urinary-/ArticleNewsFeed/Article/detail/458599?contextCategoryId=40243&ref=25 Men who develop early urinary retention after radical prostatectomy are more likely to develop a symptomatic urethral stricture, according to a prospective database report published in the August issue of Urology. 2007-09-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382007/458599/urinespecimen_40025.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382007/458599null XML http://www.modernmedicine.com/modernmedicine/Urology/Quality-of-life-is-primary-indicator-of-BPH-relate/ArticleStandard/Article/detail/454951?contextCategoryId=40243&ref=25 Of all the measurable factors a urologist must weigh when developing a prognosis for the patient with BPH, only health-related quality of life as assessed by the Benign Prostatic Hyperplasia Impact Index significantly raises the potential for surgical intervention. 2007-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362007/454951null XML http://www.modernmedicine.com/modernmedicine/BPH/Botulinum-toxin-appears-safe-effective-in-BPHLUTS/ArticleStandard/Article/detail/454961?contextCategoryId=40243&ref=25 Data from two Taiwanese studies presented at the 2007 AUA annual meeting on the use of botulinum toxin A (Botox) suggest that injections of the agent into the prostate are safe and effective in relieving the symptoms of BPH and that the treatment supplements the therapeutic benefits of medical treatment in men with larger glands. 2007-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362007/454961null XML http://www.modernmedicine.com/modernmedicine/BPH/PDE-5-inhibitors-may-play-a-role-in-BPH-LUTS/ArticleStandard/Article/detail/454960?contextCategoryId=40243&ref=25 The therapeutic role of phosphodiesterase-5 (PDE-5) inhibitors could expand to include some patients with BPH and lower urinary tract symptoms. 2007-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362007/454960null XML http://www.modernmedicine.com/modernmedicine/BPH/ED-drugs-may-offer-intriguing-therapy-for-BPHLUTS/ArticleStandard/Article/detail/449574?contextCategoryId=40243&ref=25 While urologists continue to search for the most effective means of treating BPH and lower urinary tract symptoms, research presented at the 2007 AUA annual meeting suggests that drugs they may already be prescribing for other conditions could provide a novel solution. 2007-08-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/332007/449574null XML http://www.modernmedicine.com/modernmedicine/Inflammation+and+Infection/Metabolic-syndrome-and-LUTS-An-emerging-relationsh/ArticleStandard/Article/detail/444356?contextCategoryId=40243&ref=25 Increasing evidence has recently pointed toward a relationship between LUTS secondary to BPH and the presence of metabolic syndrome. This relationship has been supported by recent epidemiologic findings. 2007-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/302007/444356null XML http://www.modernmedicine.com/modernmedicine/Oncology/Finasteride-Has-Minimal-Impact-on-Sexual-Function/ArticleNewsFeed/Article/detail/439465?contextCategoryId=40243&ref=25 The prostate cancer prevention drug finasteride has only a minor impact on sexual function and the effect diminishes over time, according to study findings published in the July 4 issue of the Journal of the National Cancer Institute. 2007-07-04T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272007/439465/33058.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272007/439465null XML http://www.modernmedicine.com/modernmedicine/Special+Section%3A+ASCRS+Cataract+News/Techniques-can-help-surgeons-manage-IFIS/ArticleStandard/Article/detail/443752?contextCategoryId=40243&ref=25 Cataract surgeons can reduce the rate of complication from intraoperative floppy iris syndrome (IFIS) by using certain techniques before and during surgery. 2007-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/302007/443752null XML http://www.modernmedicine.com/modernmedicine/Oncology/Prostate-Specific-Antigen-Density-Useful-Predictiv/ArticleNewsFeed/Article/detail/436448?contextCategoryId=40243&ref=25 The addition of prostate-specific antigen density to existing risk assessment tools could provide extra information on prostate cancer, according to the results of a study published in the June issue of Urology. 2007-06-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252007/436448/patient_18248.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252007/436448null XML http://www.modernmedicine.com/modernmedicine/BPH/PVP-TURP-show-comparable-outcomes-at-2-years/ArticleStandard/Article/detail/431387?contextCategoryId=40243&ref=25 Data from two similarly designed European studies comparing photoselective vaporization of the prostate and transurethral resection of the prostate show similar outcomes after a 2-year follow-up in patients with lower urinary tract symptoms due to BPH. 2007-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232007/431387null XML http://www.modernmedicine.com/modernmedicine/Inflammation+and+Infection/Relationship-seen-between-chronic-inflammation-LUT/ArticleStandard/Article/detail/431390?contextCategoryId=40243&ref=25 Preliminary results from the REDUCE (REduction by DUtasteride of prostate Cancer Events) trial suggest a relationship between the degree of chronic inflammation and lower urinary tract symptoms, but not clinical prostatitis-like symptoms in the REDUCE population. 2007-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232007/431390null XML http://www.modernmedicine.com/modernmedicine/BPH/New-laser-for-BPH-found-effective-safe-at-2-years/ArticleStandard/Article/detail/431401?contextCategoryId=40243&ref=25 A new continuous wave thulium laser device appears to offer a safe, bloodless, effective, and expeditious outpatient surgical procedure for men with BPH. 2007-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232007/431401null XML http://www.modernmedicine.com/modernmedicine/BPH/Lap-technique-may-play-a-role-in-treating-BPH/ArticleStandard/Article/detail/431386?contextCategoryId=40243&ref=25 A laparoscopic preperitoneal approach cannot only serve as a teaching platform for laparoscopic skills for surgeons, but it also demonstrates reproducible outcomes in the treatment of BPH. 2007-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232007/431386null XML http://www.modernmedicine.com/modernmedicine/BPH/Data-analysis-confirms-BPH-as-progressive-disease/ArticleStandard/Article/detail/431392?contextCategoryId=40243&ref=25 Results from a recent study that systematically analyzed the data of placebo-controlled trials in patients with BPH confirm that BPH is a progressive disease on the basis of worsening prostate volume, maximum urinary flow, and symptom score, as well as the rate of prostate-related surgery and acute urinary retention. 2007-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/232007/431392null XML